This holiday season, columnist Anna Jeter is searching for some silver linings in her life and to try to be grateful, despite ...

A mouse study shows overproduction of the naturally occurring hormone adrenomedullin reduced lung injury and PH in ...

Merck Canada said it has successfully completed negotiations on its PAH therapy Winrevair with the pan‑Canadian ...

Scientists identified two proteins as biomarkers of CTEPH severity and progression, a discovery that could pave the way for ...

Merck plans a Phase 3 trial of Winrevair after a Phase 2 study testing it in CpcPH due to HFpEF hit its main goal.

Low oxygen levels, or hypoxia, in early life impaired lung blood vessel growth, leading to severe pulmonary hypertension in a ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...

Columnist Anna Jeter writes that, despite any setbacks, people with pulmonary hypertension should continue to take charge of their care.

What is Flolan for pulmonary arterial hypertension? Flolan (epoprostenol sodium) is an approved intravenous infusion therapy used to improve exercise capacity in people with pulmonary arterial ...

What is Adempas for pulmonary hypertension? Adempas (riociguat) is an oral therapy approved to improve exercise capacity and World Health Organization (WHO) functional class in adults with pulmonary ...

What is Winrevair for pulmonary arterial hypertension? Winrevair (sotatercept-csrk) is an injection therapy for adults with pulmonary arterial hypertension (PAH), approved in the U.S. to improve ...

Calcimedica's CM5480 was shown to improve blood flow and heart health measurements in a rat model of PAH, a new study reports.